AstraZeneca Pharma India Limited (BOM:506820)
India
· Delayed Price · Currency is INR 8,882.30
-0.70 (-0.01%)
At close: Jun 23, 2025
AstraZeneca Pharma India Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 20, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| Market Capitalization | 222,408 | 215,159 | 133,010 | 81,183 | 63,886 | 75,255 | Upgrade
|
| Market Cap Growth | 61.76% | 61.76% | 63.84% | 27.07% | -15.11% | 25.87% | Upgrade
|
| Enterprise Value | 217,398 | 210,362 | 127,861 | 76,552 | 60,484 | 72,857 | Upgrade
|
| Last Close Price | 8896.30 | 8606.35 | 5302.47 | 3222.61 | 2529.13 | 2977.28 | Upgrade
|
| PE Ratio | 192.14 | 185.90 | 82.35 | 81.76 | 103.71 | 80.66 | Upgrade
|
| PS Ratio | 12.96 | 12.54 | 10.27 | 8.09 | 7.93 | 9.25 | Upgrade
|
| PB Ratio | 28.87 | 27.93 | 18.68 | 13.79 | 12.49 | 16.50 | Upgrade
|
| P/TBV Ratio | 28.90 | 27.95 | 18.74 | 13.79 | 12.49 | 16.50 | Upgrade
|
| P/FCF Ratio | 349.64 | 338.25 | 777.38 | 163.12 | 70.07 | 77.53 | Upgrade
|
| P/OCF Ratio | 340.28 | 329.19 | 477.25 | 139.27 | 63.38 | 71.82 | Upgrade
|
| EV/Sales Ratio | 12.67 | 12.26 | 9.87 | 7.63 | 7.51 | 8.96 | Upgrade
|
| EV/EBITDA Ratio | 85.60 | 82.83 | 69.81 | 47.45 | 73.16 | 54.94 | Upgrade
|
| EV/EBIT Ratio | 101.60 | 98.31 | 74.58 | 51.43 | 87.20 | 62.67 | Upgrade
|
| EV/FCF Ratio | 341.77 | 330.71 | 747.29 | 153.81 | 66.33 | 75.06 | Upgrade
|
| Debt / Equity Ratio | 0.05 | 0.05 | 0.01 | 0.01 | 0.02 | 0.03 | Upgrade
|
| Debt / EBITDA Ratio | 0.14 | 0.14 | 0.02 | 0.04 | 0.10 | 0.09 | Upgrade
|
| Debt / FCF Ratio | 0.56 | 0.56 | 0.27 | 0.14 | 0.10 | 0.13 | Upgrade
|
| Asset Turnover | 1.32 | 1.32 | 1.26 | 1.09 | 0.99 | 1.10 | Upgrade
|
| Inventory Turnover | 2.48 | 2.48 | 2.87 | 2.22 | 2.11 | 1.85 | Upgrade
|
| Quick Ratio | 1.03 | 1.03 | 1.89 | 1.61 | 1.64 | 1.46 | Upgrade
|
| Current Ratio | 1.91 | 1.91 | 2.61 | 2.18 | 2.12 | 2.04 | Upgrade
|
| Return on Equity (ROE) | 15.62% | 15.62% | 24.84% | 18.05% | 12.73% | 22.74% | Upgrade
|
| Return on Assets (ROA) | 10.30% | 10.30% | 10.39% | 10.11% | 5.32% | 9.81% | Upgrade
|
| Return on Capital (ROIC) | 17.57% | 17.57% | 16.33% | 16.67% | 8.77% | 17.21% | Upgrade
|
| Return on Capital Employed (ROCE) | 26.30% | 26.30% | 23.80% | 24.80% | 13.20% | 24.70% | Upgrade
|
| Earnings Yield | 0.52% | 0.54% | 1.21% | 1.22% | 0.96% | 1.24% | Upgrade
|
| FCF Yield | 0.29% | 0.30% | 0.13% | 0.61% | 1.43% | 1.29% | Upgrade
|
| Dividend Yield | 0.36% | 0.37% | 0.45% | 0.50% | 0.40% | 0.07% | Upgrade
|
| Payout Ratio | 51.84% | 51.84% | 24.77% | 20.14% | 8.12% | 5.36% | Upgrade
|
| Buyback Yield / Dilution | 0.01% | 0.01% | - | - | - | - | Upgrade
|
| Total Shareholder Return | 0.33% | 0.38% | 0.45% | 0.50% | 0.40% | 0.07% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.